Showing results (161-170 of 316) with videos related to

Sort By:
Pageof 32
Cancer|September 18, 2008
Perceived family history risk and symptomatic diagnosis of prostate cancer: the North Carolina Prostate Cancer Outcomes studyPamela Spain, William R Carpenter, James A Talcott, et al.
Cancer Causes & Control : CCC|September 25, 2009
Race, healthcare access and physician trust among prostate cancer patientsYoung Kyung Do, William R Carpenter, Pamela Spain, et al.
Genes & Development|April 1, 1995
Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instabilityL A Donehower, L A Godley, C M Aldaz, et al.
JAMA Internal Medicine|May 22, 2013
Comparative effectiveness of intensity-modulated radiotherapy and conventional conformal radiotherapy in the treatment of prostate cancer after radical prostatectomyGregg H Goldin, Nathan C Sheets, Anne-Marie Meyer, et al.
Human Molecular Genetics|June 20, 2014
Linking the genetic architecture of cytosine modifications with human complex traitsXu Zhang, Erika L Moen, Cong Liu, et al.
Scientific Reports|December 4, 2015
TET-catalyzed 5-hydroxymethylcytosine regulates gene expression in differentiating colonocytes and colon cancerChristopher G Chapman, Christopher J Mariani, Feng Wu, et al.
Stem Cell Research|February 5, 2026
Generation of an induced pluripotent stem cell line CGOi001-A from a patient with hereditary thrombocytopenia and a germline ANKRD26 mutationAubrianna S Ramsland, Karolina Dudek, Kelsey E McNeely, et al.
Leukemia & Lymphoma|October 14, 2009
Patterns and kinetics of T-cell chimerism after allo transplant with alemtuzumab-based conditioning: mixed chimerism protects from GVHD, but does not portend disease recurrenceKoen van Besien, Alexander Dew, Shang Lin, et al.
BJC Reports|March 28, 2025
Germline copy number variants in RUNX1: An updated case report and a decade-old red herringNatalie T Deuitch, Amra Kajdic, Erica Bresciani, et al.
The Prostate|May 6, 2006
The North Carolina-Louisiana Prostate Cancer Project (PCaP): methods and design of a multidisciplinary population-based cohort study of racial differences in prostate cancer outcomesJane C Schroeder, Jeannette T Bensen, L Joseph Su, et al.
Pageof 32